Top Pharmacovigilance Trend in 2017: The Expanding Role of Pharmacovigilance in Rapidly Changing Regulatory and Commercial Climates by ProductLife Group Monday 13 February 2017 PDF Print The findings, uncovered in a series of in-depth interviews with key industry players, will be discussed at a special Webinar featuring senior speakers Paris — February 13th, 2017 — An important new industry study from ProductLife Group highlights the ways good-pharmacovigilance-practice (GVP) guidelines, increased globalisation, and heightened business demands have propelled pharmacovigilance up the life sciences agenda and expanded the demands and challenges regulatory teams face. Implications for safety and quality assurance extend far beyond the boundaries of regulatory affairs by requiring advance cooperation and data sharing between a range of operational functions. A further trend is an emphasis on risk–benefit balance: companies are now expected to consider the benefits of a product in terms of what it means to patients. Intensifying commercial pressures also have a bearing on the role of pharmacovigilance to the extent that a new type of pharmacovigilance professional is now emerging—one who blends expertise in safety and quality with a rounded understanding of global regulations and requirements as well as business and budget management expertise. The study highlights: • The effect GVP guidelines are having on the role of pharmacovigilance and its relationship with quality • The role safety must play in the decision-making process • Skills gaps and recruitment implications • Global complexities, including different regions’ changing GVP requirements and the implications for affiliates Drawing on the findings, captured through in-depth interviews with key life sciences industry figures, PLG Evolve—ProductLife Group’s thought leadership programme—will present a Webinar detailing the top pharmacovigilance trends for 2017, the effects they’ll have on the expanding role of pharmacovigilance, and the challenges faced by those involved. Speakers • Guest presenter Lesley Wise, PhD, is managing director of Wise Pharmacovigilance and Risk Management, a consultant to companies, contract research organisations, and independent research groups. She has more than 15 years of experience in pharmacovigilance both in medicines regulation as head of the risk management and pharmacoepidemiology group at the Medicines and Healthcare products Regulatory Agency and in the pharmaceutical industry, most recently at Takeda Pharmaceuticals. Lesley has a doctorate in statistical genetics/genetic epidemiology. She is an honorary lecturer in pharmacoepidemiology at the London School of Hygiene & Tropical Medicine and an associate editor of Therapeutic Advances in Drug Safety. • Erick Gaussens, PhD, is chief scientific officer at ProductLife Group. He has deep knowledge of risk management and regulatory requirements in the life sciences industry and brings immeasurable expertise in cognitive science. His extensive R&D experience across several innovative and highly regulated industries gives him unique insight into the impacts of new regulations, new technologies, and the evolution of product life cycle management from both information management and business process perspectives. Erick’s doctorate in mathematics and Docteur d’État are from Université Paris-Dauphine. • Cheryl Key, MBBS, is head of pharmacovigilance platform services and principal PV medic at ProductLife Group. She has gained more than 16 years of drug safety experience by working at pharmaceutical and biotech companies, for contract research organisations, and for regulatory authorities. Before joining what is now the Medicines and Healthcare products Regulatory Agency, Cheryl spent several years in medical practice. She has a medical degree from Charing Cross and Westminster Medical School. Webinar details Date: 23 February 2017 Time: 2–3 p.m. CET To register, go to: https://productlifegroup.com/news/webinar/ Upon sign-up, registrants will be notified of a white paper on assessment of the expanding role of pharmacovigilance, which will be available for download in pdf. About ProductLife Group ProductLife Group is a trusted partner that helps clients stay ahead of the changing R&D landscape. We provide support across all stages of the product life cycle and have experience in working with companies in every segment of the life sciences industry. With an established presence across Europe, North America, and Asia Pacific; with extensive capabilities in key markets; and with more than two decades of serving the industry, ProductLife Group has a solid platform from which to provide clients a range of services, consulting, and outsourcing solutions. ProductLife Group empowers clients to focus on innovation and business growth strategies and to make strong, informed decisions every step of the way. What’s more, we wrap it all up with partnership flexibility, for a truly customised experience that helps clients scale their initiatives cost-effectively. By taking advantage of the power of deep domain expertise, established relationships, intelligent collaborations, and a flexible delivery framework, ProductLife Group delivers exceptional service to clients. Our goal is to develop long-term relationships by being responsive and relevant and by consistently delivering value. We cultivate a trusting, consultative environment and are positioned to operate as an extension of clients’ businesses, with a shared interest in their long-term success. More at productlifegroup.com or follow us on Twitter at @ProductLife_EU. PR Contact: Sarum PR – PR for ProductLife Group +44 1722 322916 firstname.lastname@example.org This press release was distributed by ResponseSource Press Release Wire on behalf of Sarum PR in the following categories: Business & Finance, Medical & Pharmaceutical, Computing & Telecoms, for more information visit http://pressreleasewire.responsesource.com/about.